3 Stocks Down 20% Or More That Are Must Buys Now
Briefly

We believe we have an incredible product and incredible future pipeline and an unparalleled market opportunity. I expect more for myself and more from my team going forward.
Earlier this year, Dexcom expanded availability of its One+ product, now in 18 international markets, despite facing a 41% decline in stock value in 2024.
Read at 24/7 Wall St.
[
]
[
|
]